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When 6-azauracil was subcutaneously injected, fl-aminoisobutyric acid and /3-alanine contents were 
increased 23 and 61-fold, respectively, in rat liver. Incorporation of [methyl-%]thymine into /I-aminoiso- 
butyric acid was increased to 42-fold by 6-azauracil treatment. The absolute configuration of this amino 
acid was proved to be the (@-form by means of a gas-chromatographic technique. 6-Azauracil nhibited 
/?-alanine-pyruvate aminotransferase ctivity with an Iso of approx. 2.5 mM. 
/I-Aminoisobutyric acid B-Alanine 6-Azauracil Thymine /I-Alanine-pyruvate aminotransferase 
1. INTRODUCTION 
It is well known that 6-azauracil and its 
derivatives act as a metabolic inhibitor for RNA 
synthesis. 6-Azauridine 5 ‘-phosphate is a com- 
petitive inhibitor of orotidine-5 ’-phosphate decar- 
boxylase [l]. Moreover, the mode of action of 
6azauridine in its capacity as a growth inhibitor 
has been attributed to inhibition of UTP biosyn- 
thesis by 6-azauridine 5 ‘-phosphate [2] or incor- 
poration of it into RNA [3]. In [4-61, we found 
that ,&alanine content in rat liver was remarkably 
increased by injection of 6-azauracil and that 
6-azauracil was a competitive inhibitor of purified 
,&alanine-2-oxoglutarate aminotransferase (EC 
2.6.1.19) from rabbit liver. Slavik et al. [7] also 
proposed that 6-azauridine triacetate induced 
hyper ,&alaninemia. 
,&AIB is an end product of the metabolic 
degradation of thymine [8,9], its absolute con- 
figuration being of the @)-form [lO,ll]. Solem et 
al. [11,12] found the @)-isomer present in serum, 
which must have a different metabolic origin than 
from thymine degradation. The (R)- and (s)- 
enantiomers of &AIB were transaminated by dif- 
Abbreviation: fl-AIB, fl-aminoisobutyric a id 
ferent enzymes such as ,&AIB-pyruvate amino- 
transferase (@-alanine-pyruvate aminotransferase, 
EC 2.6.1.18) and ,&AIB-2-oxoglutarate amino- 
transferase (L-3-aminoisobutyrate aminotransfer- 
ase, EC 2.6.1.22), respectively [13,141. 
This report describes the increase of P-AIB 
caused by 6-azauracil with the concomitant de- 
crease of the activity of @alanine-pyruvate amino- 
transferase in vivo and the absolute configuration 
of this amino acid was proved to be the (R)-enan- 
tiomorph. 
2. MATERIALS AND METHODS 
All chemicals used were of analytical grade and 
purchased from Nakarai Chemicals, Kyoto, if not 
otherwise stated. 6-Azauracil was obtained from 
Sigma. [methyZ-14C]Thymine was purchased from 
Commissariat a 1’Energie Atomique, France, and 
&[2-‘4C]alanine from New England Nuclear, 
USA. Pure (R)- and @)-isomers of ,&AIB were 
kindly provided by Professor Y. Kakimoto of 
School of Medicine, Ehime University, Japan. 
Male Sprague-Dawley rats, weighing 120-150 g, 
were housed in individual screen-bottomed cages 
in a room maintained at 23 + 1°C with 50% 
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humidity and light regulation (12 h light per day). 
The animals were fed on a commercial stock diet 
(Oriental Kobe) and water ad libitum for 1 week 
before the experiment o acclimatize them to the 
new environment. 
2.1. Preparation of sample for DNA-RNA and 
amino acid analysis 
Preparations of a DNA-RNA fraction and a 
sample for amino acid analysis from rat liver were 
according to [4,15]. 
2.2. Amino acid and gas-chromatographic 
analysis 
The quantitative determination and fractiona- 
tion of amino acids were performed with a 
preparative amino acid autoanalyzer (Hitachi 
KLA-3B type) and an aliquot of the,&AIB fraction 
was saved for estimation of radioactivity and 
determination of the absolute configuration of the 
amino acid. The radioactivity was measured with a 
Packard liquid scintillation counter equipped with 
an external standard for compensating counting 
efficiency. The P-AIB fraction from the 
preparative amino acid analyzer was desalted as 
shown by Ogawa et al. [16] and converted to the N- 
trifluoroacetyl-(S)-prolyl derivative of the methyl 
ester of fi-AIB by the method of Bonner [17]. The 
enantiomers of the dipeptides were separated 
isothermally at 185°C using a 3 mm x 2 m column 
containing 2% OV 17 on gas chromatography 
(Yanagimoto). 
2.3. Assay of fl-alanine-pyruvate 
aminotransferase 
fi-Alanine-pyruvate aminotransferase activity 
was assayed by following the rate of formation of 
malonic semialdehyde according to [ 181. 
3. RESULTS 
Table 1 shows the incorporation of radioactivity 
into ,&AIB in rat liver 20 min after 
[methyl-r4C]thymine administration. The position 
of the radioactivity on paper chromatography (n- 
butanol : acetic acid : water = 4 : 4 : 1) was the same 
as that of fi-AIB. The conversion of radioactive 
thymine into fl-AIB was increased very significant- 
ly by 6-azauracil. In livers of rats treated with 
6-azauracil the radioactivity of @-AIB was 37% of 
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Table 1 
Incorporation of [methyl-‘4C]thymine i to P-AIB in rat 
liver 
Treatment dpm/g wet tissue % of injection 
Control lo3 x ( 23.9 f 1.2) 0.86 f 0.05 
6-Azauracil lo3 x (1004.2 f 55.5)a 37.61 f 1.59a 
Five rats were used in each experimental subgroup. 
10 mg 6-azauracil was dissolved in 0.4 ml of 2OVo 
propylene glycol and subcutaneously injected into the 
rats 5 times at intervals of 2 h. Control animals were 
injected with 20% propylene glycol in the same manner. 
2 h after the last injection of 6azauraci1, 10&i 
[methyl-14C]thymine (50 mCi/mmol) was injected into 
the femoral vein and the animals killed 20 min later. The 
liver was quickly removed and provided as the sample 
preparations. Each value is the mean f SE. a p < 0.01 
compared to control 
Table 2 
Effect of 6-azauracil on &AIB and 18-alanine contents in 
rat liver 
Treatment fimol/g wet tissue 
,&AIB fl-Alanine 
Control 0.040 * 0.003 0.180 f 0.028 
6-Azauracil 0.849 f 0.037a 10.950 f 0.572a 
6-Azauracil treatment and autopsy were the same as in 
table 1. Each value is the mean * SE. a p < 0.01 
compared to control 
the total radioactivity injected, while that in con- 
trol rat liver was 0.9%. On the other hand, the 
radioactivities of the DNA + RNA fraction in liver 
of control and 6-azauracil-treated rat were 0.32 
and 0. 1 l%, respectively, of [methyl-‘4C]thymine 
administered. 
Table 2 shows the contents of ,&AIB as well as 
P-alanine in rat liver and the effect of 6azauracil. 
When 6azauracil was consecutively injected 5 
times at intervals of 2 h, the levels of &AIB and p- 
alanine were increased very significantly, 22- and 
61-fold, respectively. 
By application. of gas-liquid chromatography, 
the enantiomorphs of &AIB in liver could be 
determined. Authentic N-trifluoroacetyl-(S)-pro- 
lyl-(R)-P-AIB methyl ester was separated from the 
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Fig. 1. Gas-chromatographic determination f the ,&AIB 
enantiomorph in liver of rat administered with 
6-azauracil. 6-Azauracil was injected as described in 
table 1. Sample preparation and gas-chromatographic 
conditions are described in section 2. (a) Control rat 
liver, (b) 6-azauracil-treated rat liver, (c) (b) + authentic 
N-trifluoroacetyl-(S)-prolyl-(R)-P_AIB methyl ester. 
derivative of the @)-isomer (not shown). As shown 
in fig.1, the striking accumulation of the (R)- 
enantiomer of ,&AIB was observed in liver of rat 
injected with 6-azauracil and the peak of the 
derivative of the @)-isomer was increased by the 
addition of the authentic one. Thus, it is apparent 
that the increase of liver total fi-AIB was caused by 
the (Z?)-enantiomorph only. 
Fig.2 shows the inactivation of fl-alanine- 
pyruvate aminotransferase activity by 6-azauracil. 
The enzyme activity in raw extract of rat liver was 
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Fig.2. Effect of 6-azauracil on ,&alanine-pyruvate 
aminotransferase activity in rat liver. Rat liver was 
homogenized in 10 mM potassium phosphate, pH 7.5, 
containing 1 mM EDTA, 2 mM 2-mercaptoethanol and 
40 pM pyridoxal 5 ‘-phosphate. The homogenate was 
centrifuged for 20 min at 27000 x g and the supernatant 
used for the estimation of enzyme activity. Relative 
activity is defined as the percentage of the activity 
compared to that in the absence of 6-azauracil. 
0.17 f 0.02 nmol/min per mg protein under the 
standard assay conditions. In the presence of 
1 mM /3-alanine and 10 mM pyruvate, 6-azauracil 
inactivated ,&alanine-pyruvate aminotransferase 
activity with an apparent ZSO of 2.5 mM. 
4. DISCUSSION 
Here, the (R)-isomer of @-AIB was accumulated 
in rat liver by 6-azauracil treatment (table 2, fig. 1). 
These results show that 6-azauracil increased one 
of the metabolites of thymine. The incorporation 
of radioactivity from [methyl-14C]thymine into fl- 
AIB in liver was increased 42-fold by 6-azauracil. 
Furthermore, 6-azauracil inhibited uridine 5 ’ - 
phosphate synthesis [l] and decreased the incor- 
poration of [methyl-‘4C]thymine into DNA. From 
these results, it may be proposed that 6-azauracil 
does not enhance pyrimidine biosynthesis, but that 
it inhibits the metabolism of (Z?)-,&AIB. As shown 
in fig.2, 6-azauracil inactivated ,&alanine-pyruvate 
aminotransferase activity in rat liver. 
In [6,18], we found that &alanine was mainly 
transaminated by @-alanine-2-oxoglutarate ami- 
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notransferase in liver and that 6-azauracil inhibited 
the purified enzyme activity. In this paper we also 
found that 6-azauracil inactivated ,&-alanine- 
pyruvate aminotransferase activity to accumulate 
(R)-&AIB. Thus, 6-azauracil may facilitate the 
study of pyrimidine metabolism including ,&- 
alanine and (R)-/3-AIB. 
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